Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL3765499

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
CN1CCN(CCCOc2ccc(N3C(=O)/C(=C/c4ccc(Oc5ccc(F)cc5)cc4)SC3=S)cc2)CC1

Basic Information

ChEMBL ID CHEMBL3765499
Phase Preclinical
Structure Type MOL
InChI Key UVNFVYYNRZPREN-HFTWOUSFSA-N
2
Targets
2
Activities
1
Assay Types
12
PK Parameters
20
Publications
0
Known Names

Molecular Properties

563.7
MW (Da)
6.04
ALogP
7
HBA
0
HBD
45.2
PSA (Ų)
0.18
QED
2
Ro5 Violations
9
Rot. Bonds

Drug Information

Molecule Type Small molecule
Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C30H30FN3O3S2
MW 563.72
Aromatic Rings 3
Heavy Atoms 39
NP-Likeness -1.63

Activity Summary

IC50 2 meas. best 6.3

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Inhibitor of nuclear factor kappa-B kinase subunit beta
CHEMBL6012
IC50 6.3 6.3 500.0 1
Inhibitor of nuclear factor kappa-B kinase subunit beta
CHEMBL1991
IC50 6.1 6.1 790.0 1

Pharmacokinetic Data

Parameter Value Units Species
AUC 175.6 ng.hr.mL-1 Rattus norvegicus
AUC 79.4 ng.hr.mL-1 Rattus norvegicus
CL 98.0 mL.min-1.kg-1 Rattus norvegicus
CL 97.67 mL.min-1.kg-1 Rattus norvegicus
Cmax 166.73 nM Rattus norvegicus
Cmax 15.26 nM Rattus norvegicus
F 23.0 % Rattus norvegicus
T1/2 3.983 hr Homo sapiens
T1/2 5.5 hr Rattus norvegicus
T1/2 5.81 hr Rattus norvegicus
Vd 44.33 L.kg-1 Rattus norvegicus
Vd 50.58 L.kg-1 Rattus norvegicus

Activity Data Samples

Top measurements by pChEMBL value

Literature References

PubMed DOI Target Context # Activities
26826731 10.1016/j.bmcl.2016.01.065 Mus musculus 15
26826731 10.1016/j.bmcl.2016.01.065 Rattus norvegicus 11
26826731 10.1016/j.bmcl.2016.01.065 Inhibitor of nuclear factor kappa-B kinase subunit beta 5
26826731 10.1016/j.bmcl.2016.01.065 MAP kinase-activated protein kinase 2 2
26826731 10.1016/j.bmcl.2016.01.065 Unchecked 2
26826731 10.1016/j.bmcl.2016.01.065 CDK2/Cyclin A2 1
26826731 10.1016/j.bmcl.2016.01.065 Casein kinase I isoform delta 1
26826731 10.1016/j.bmcl.2016.01.065 Serine/threonine-protein kinase Chk2 1
26826731 10.1016/j.bmcl.2016.01.065 CDK9/cyclin T1 1
26826731 10.1016/j.bmcl.2016.01.065 Cyclin-dependent kinase 7/ cyclin H 1
26826731 10.1016/j.bmcl.2016.01.065 CDK6/cyclin D1 1
26826731 10.1016/j.bmcl.2016.01.065 Cyclin-dependent kinase 5/CDK5 activator 1 1
26826731 10.1016/j.bmcl.2016.01.065 Cyclin-dependent kinase 4/cyclin D1 1
26826731 10.1016/j.bmcl.2016.01.065 Calcium/calmodulin-dependent protein kinase type 1 1
26826731 10.1016/j.bmcl.2016.01.065 Proto-oncogene tyrosine-protein kinase Src 1
26826731 10.1016/j.bmcl.2016.01.065 Serine/threonine-protein kinase B-raf 1
26826731 10.1016/j.bmcl.2016.01.065 Aurora kinase B 1
26826731 10.1016/j.bmcl.2016.01.065 Aurora kinase A 1
26826731 10.1016/j.bmcl.2016.01.065 Tyrosine-protein kinase ABL1 1
26826731 10.1016/j.bmcl.2016.01.065 ADMET 1

Data from ChEMBL 36 via Core Engine